Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library

被引:15
作者
Zhou, Mingkui [1 ]
Meyer, Torsten [2 ]
Koch, Stefanie [3 ]
Koch, Joachim [1 ]
von Briesen, Hagen [3 ]
Benito, Jose M. [4 ]
Soriano, Vincent [4 ]
Haberl, Annette [5 ]
Bickel, Markus [5 ]
Duebel, Stefan [2 ]
Hust, Michael [2 ]
Dietrich, Ursula [1 ]
机构
[1] Inst Biomed Res, Frankfurt, Germany
[2] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, Braunschweig, Germany
[3] Fraunhofer Inst Biomed Engn, St Ingbert, Germany
[4] Hosp Carlos III, Infect Dis Dept, Madrid, Spain
[5] Goethe Univ Frankfurt, Sch Med, HIV Ctr, D-60054 Frankfurt, Germany
基金
比尔及梅琳达.盖茨基金会;
关键词
Elite controllers; Epitopes; HIV-1; neutralizing antibodies; phage display; IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; B-CELL RESPONSES; VACCINE DESIGN; HIV-1-INFECTED INDIVIDUALS; ELITE CONTROLLERS; GENE LIBRARIES; INFECTION; BROAD; 2F5;
D O I
10.1002/eji.201242974
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV controllers are a valuable source for the identification of HIV-neutralizing antibodies, as chronic infection over decades allows extensive affinity maturation of antibodies for improved Ag recognition. We analyzed a small cohort of elite controllers (ECs) for HIV-neutralizing antibodies using a panel of standardized HIV-1 pseudovirions on TZM-bl cells. An HIV-1 Env-tailored phage display library was generated to select epitopes targeted by neutralizing antibodies in the EC26 plasma sample showing the broadest neutralizing activity. Selected Env fragments were mostly allocated to the membrane proximal external region of gp41. After preabsorbing the EC26 plasma with the selected phage EC26-2A4, we achieved 50% depletion of its neutralizing activity. Furthermore, antibodies affinity-purified with the EC26-2A4 epitope from EC26 plasma showed neutralizing activity, proving that the selected phage indeed contains an epitope targeted by neutralizing plasma antibodies. Epitope fine mapping of the purified plasma antibodies on peptide arrays identified a new epitope overlapping, but clearly distinct, from the prominent 2F5 epitope. Of note, the purified antibodies did not show autoreactivity with cardiolipin, whereas low reactivity with phosphatidylserine comparable to mAb 2F5 was observed. Thus, this new epitope represents a promising candidate for further analysis in view of HIV vaccine development.
引用
收藏
页码:499 / 509
页数:11
相关论文
共 85 条
[1]   Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: Antibody binding kinetics, induction, and potential for regulation in acute infection [J].
Alam, S. Munir ;
Scearce, Richard M. ;
Parks, Robert J. ;
Plonk, Kelly ;
Plonk, Steven G. ;
Sutherland, Laura L. ;
Gorny, Miroslaw K. ;
Zolla-Pazner, Susan ;
VanLeeuwen, Stacie ;
Moody, M. Anthony ;
Xia, Shi-Mao ;
Montefiori, David C. ;
Tomaras, Georgia D. ;
Weinhold, Kent J. ;
Karim, Salim Abdool ;
Hicks, Charles B. ;
Liao, Hua-Xin ;
Robinson, James ;
Shaw, George M. ;
Haynes, Barton F. .
JOURNAL OF VIROLOGY, 2008, 82 (01) :115-125
[2]   Role of HIV membrane in neutralization by two broadly neutralizing antibodies [J].
Alam, S. Munir ;
Morelli, Marco ;
Dennison, S. Moses ;
Liao, Hua-Xin ;
Zhang, Ruijun ;
Xia, Shi-Mao ;
Rits-Volloch, Sophia ;
Sun, Li ;
Harrison, Stephen C. ;
Haynes, Barton F. ;
Chen, Bing .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (48) :20234-20239
[3]   Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection [J].
Baba, TW ;
Liska, V ;
Hofmann-Lehmann, R ;
Vlasak, J ;
Xu, WD ;
Ayehunie, S ;
Cavacini, LA ;
Posner, MR ;
Katinger, H ;
Stiegler, G ;
Bernacky, BJ ;
Rizvi, TA ;
Schmidt, R ;
Hill, LR ;
Keeling, ME ;
Lu, YC ;
Wright, JE ;
Chou, TC ;
Ruprecht, RM .
NATURE MEDICINE, 2000, 6 (02) :200-206
[4]   Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy [J].
Bailey, Justin R. ;
Lassen, Kara G. ;
Yang, Hung-Chih ;
Quinn, Thomas C. ;
Ray, Stuart C. ;
Blankson, Joel N. ;
Siliciano, Robert F. .
JOURNAL OF VIROLOGY, 2006, 80 (10) :4758-4770
[5]   Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C [J].
Binley, James M. ;
Lybarger, Elizabeth A. ;
Crooks, Emma T. ;
Seaman, Michael S. ;
Gray, Elin ;
Davis, Katie L. ;
Decker, Julie M. ;
Wycuff, Diane ;
Harris, Linda ;
Hawkins, Natalie ;
Wood, Blake ;
Nathe, Cory ;
Richman, Douglas ;
Tomaras, Georgia D. ;
Bibollet-Ruche, Frederic ;
Robinson, James E. ;
Morris, Lynn ;
Shaw, George M. ;
Montefiori, David C. ;
Mascola, John R. .
JOURNAL OF VIROLOGY, 2008, 82 (23) :11651-11668
[6]  
Brandt O., 2009, CURR CHEM BIOL, V3, P171
[7]   Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications [J].
Bryson, Steve ;
Julien, Jean-Philippe ;
Hynes, Rosemary C. ;
Pai, Emil F. .
JOURNAL OF VIROLOGY, 2009, 83 (22) :11862-11875
[8]   Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses [J].
Burton, Dennis R. ;
Poignard, Pascal ;
Stanfield, Robyn L. ;
Wilson, Ian A. .
SCIENCE, 2012, 337 (6091) :183-186
[9]   A Boost for HIV Vaccine Design [J].
Burton, Dennis R. ;
Weiss, Robin A. .
SCIENCE, 2010, 329 (5993) :770-773
[10]   HIV vaccine design and the neutralizing antibody problem [J].
Burton, DR ;
Desrosiers, RC ;
Doms, RW ;
Koff, WC ;
Kwong, PD ;
Moore, JP ;
Nabel, GJ ;
Sodroski, J ;
Wilson, IA ;
Wyatt, RT .
NATURE IMMUNOLOGY, 2004, 5 (03) :233-236